← Back to Discover
Rosalind Advisors, Inc.
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $269,201,776
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- DELCATH SYSTEMS, INC. · COM NEW · 24661P807 · shares: $41,551,898
- FENNEC PHARMACEUTICALS INC · COM · 31447P100 · shares: $34,271,011
- XERIS BIOPHARMA HOLDINGS INC · COM · 98422E103 · shares: $23,039,130
- SAVARA INC · COM · 805111101 · shares: $19,577,225
- VERASTEM INC · COM NEW · 92337C203 · shares: $15,228,464
- X4 PHARMACEUTICALS INC · COM NEW · 98420X202 · shares: $15,012,957
- EYEPOINT PHARMACEUTICALS INC · COM NEW · 30233G209 · shares: $14,131,689
- CYBIN INC · COM NEW · 23256X407 · shares: $12,934,541
- VOR BIOPHARMA INC · COM NEW · 929033207 · shares: $11,940,726
- VAXCYTE INC · COM · 92243G108 · shares: $11,626,000
Reported holdings
35 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | COM NEW | 24661P807 | — | 3,300,389 shares | $41,551,898 |
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | — | 3,188,001 shares | $34,271,011 |
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | — | 2,908,981 shares | $23,039,130 |
| SAVARA INC | COM | 805111101 | — | 3,178,121 shares | $19,577,225 |
| VERASTEM INC | COM NEW | 92337C203 | — | 3,986,509 shares | $15,228,464 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 3,214,766 shares | $15,012,957 |
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | — | 988,230 shares | $14,131,689 |
| CYBIN INC | COM NEW | 23256X407 | — | 1,956,814 shares | $12,934,541 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 648,600 shares | $11,940,726 |
| VAXCYTE INC | COM | 92243G108 | — | 200,000 shares | $11,626,000 |
| MEDIWOUND LTD | SHS NEW | M68830112 | — | 749,054 shares | $11,011,094 |
| CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | — | 200,000 shares | $7,442,000 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 721,504 shares | $7,215,040 |
| PROFOUND MEDICAL CORP | COM NEW | 74319B502 | — | 828,118 shares | $5,506,985 |
| TALPHERA INC | COM NEW | 00444T209 | — | 5,169,501 shares | $5,324,586 |
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | — | 1,070,550 shares | $4,978,058 |
| MYOMO INC | COM NEW | 62857J201 | — | 3,637,886 shares | $3,783,401 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 1,107,994 shares | $2,980,504 |
| NEURAXIS INC | COM | 64134X201 | — | 508,055 shares | $2,971,106 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 20,869 shares | $2,781,003 |
| INSPIREMD INC | COM | 45779A846 | — | 3,905,743 shares | $2,734,411 |
| REGENTIS BIOMATERIALS LTD | ORDINARY SHARES | M8211G108 | — | 701,685 shares | $2,476,948 |
| SELLAS LIFE SCIENCES GROUP INC | PUT | 81642T959 | PUT | 568,700 shares | $2,302,500 |
| POLYPID LTD | COM | M8001Q126 | — | 389,455 shares | $1,978,431 |
| BIOFRONTERA INC | COM NEW | 09077D209 | — | 1,275,609 shares | $1,206,088 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 100,000 shares | $1,097,000 |
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | — | 20,000 shares | $1,080,000 |
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | — | 250,000 shares | $1,040,000 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 150,000 shares | $684,000 |
| PEPGEN INC | COM | 713317105 | — | 350,000 shares | $630,000 |
| CG ONCOLOGY INC | CALL | 156944900 | CALL | 31,000 shares | $375,100 |
| EYEPOINT PHARMACEUTICALS INC | CALL | 30233G909 | CALL | 50,300 shares | $130,780 |
| ISHARES TR | PUT | 464287955 | PUT | 500,000 shares | $110,000 |
| SPDR SERIES TRUST | PUT | 78464A950 | PUT | 140,600 shares | $35,150 |
| TENAX THERAPEUTICS INC | PUT | 88032L955 | PUT | 6,200 shares | $13,950 |